Case Report
Published on 19 Dec 2024
Severe liver injury induced by minocycline in hepatitis B patient: a Case Report
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1516217
- 1,007 views
Type at least 3 characters
585 articles
Review
Published on 16 Dec 2024
Pediatric flecainide pharmacogenomics: a roadmap to delivering precision-based care to pediatrics arrhythmias
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477485
- 824 views
Original Research
Published on 11 Dec 2024
Paromomycin targets HDAC1-mediated SUMOylation and IGF1R translocation in glioblastoma
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1490878
- 738 views
Brief Research Report
Published on 05 Dec 2024
Clinical implications of a gain-of-function genetic polymorphism in DPYD (rs4294451) in colorectal cancer patients treated with fluoropyrimidines
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1516375
- 1,028 views
Original Research
Published on 04 Dec 2024
AH-6809 mediated regulation of lung adenocarcinoma metastasis through NLRP7 and prognostic analysis of key metastasis-related genes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1486265
- 1,136 views
Original Research
Published on 03 Dec 2024
Pharmacogenomic profiling of the South Korean population: Insights and implications for personalized medicine
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1476765
- 1,801 views
Review
Published on 28 Nov 2024
Advancements in precision medicine: multi-omics approach for tailored metformin treatment in type 2 diabetes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1506767
- 1,777 views
- 1 citation
Original Research
Published on 25 Nov 2024
Comparing commercial pharmacogenetic testing results and recommendations for antidepressants with established CPIC guidelines
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1500235
- 1,145 views
Original Research
Published on 20 Nov 2024
Metabolic pathways, genomic alterations, and post-translational modifications in pulmonary hypertension and cancer as therapeutic targets and biomarkers
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1490892
- 1,552 views
Original Research
Published on 18 Nov 2024
Investigation on regulation of N-acetyltransferase 2 expression by nuclear receptors in human hepatocytes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488367
- 945 views
Original Research
Published on 15 Nov 2024
Population pharmacokinetic study of the effect of polymorphisms in the ABCB1 and CES1 genes on the pharmacokinetics of dabigatran
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1454612
- 688 views
Original Research
Published on 14 Nov 2024
Novel genomic variants influencing methotrexate delayed clearance in pediatric patients with acute lymphoblastic leukemia
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1480657
- 1,206 views
Review
Published on 12 Nov 2024
Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1442888
- 3,202 views
- 3 citations
Original Research
Published on 01 Nov 2024
Multi-omics association study integrating GWAS and pQTL data revealed MIP-1α as a potential drug target for erectile dysfunction
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1495970
- 1,664 views
Original Research
Published on 01 Nov 2024
Allele frequencies and genotype distribution of three metformin transporter polymorphisms in Mexican population and their application in pharmacogenomics of type 2 diabetes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1466394
- 1,021 views
Original Research
Published on 30 Oct 2024
The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1483723
- 1,087 views